1001-5256
2016 Issue 9
Potential clinical significance of serum HBV RNA virus-like particles
zhong hua gan zang bing za zhi she ;, lin chuang gan dan bing za zhi she ;, gan zang za zhi she ;
zhong hua gan zang bing za zhi she ;, lin chuang gan dan bing za zhi she ;, gan zang za zhi she ;
..............page:1635-1636
..............page:1637-1643
..............page:1643,1652,1658,1663,1667,1672,1677,1683,1738,1742,
..............page:1644-1652
An excerpt of KASL clinical practice guidelines: management of chronic hepatitis B (2016)
LI Jun;,XU Baiguo;
LI Jun;,XU Baiguo;
..............page:1653-1658
An excerpt of the Japanese Society of Gastroenterology of evidence-based clinical practice guidelines for liver cirrhosis(2015)
ZHANG Hong;,HAN Jing;
ZHANG Hong;,HAN Jing;
..............page:1659-1663
National Cancer Centre Singapore consensus guidelines for hepatocellular carcinoma(2016)
ZHANG Hao;,TIAN She;
ZHANG Hao;,TIAN She;
..............page:1664-1667
Current status of liver failure treatment
MA Zhen;,WU Yun;
MA Zhen;,WU Yun;
..............page:1668-1672
Disease assessment and prognosis of liver failure
ZHANG Jing;,ZHOU Xinmin;
ZHANG Jing;,ZHOU Xinmin;
..............page:1673-1677
Research advances in clinical diagnosis, prognostic evaluation, and treatment of liver failure
LIN Feng;
LIN Feng;
..............page:1678-1683
Definition, pathophysiology, and clinical management of acute-on-chronic liver failure
LIU Haixia;,ZHU Yueke;,MENG Qinghua;
LIU Haixia;,ZHU Yueke;,MENG Qinghua;
..............page:1684-1687
Advances in diagnosis and treatment of patients with acute-on-chronic liver failure complicated by acute kidney injury
li xiao peng ;, wu zhen ping ;, zhang lun li ;, li ming ;
li xiao peng ;, wu zhen ping ;, zhang lun li ;, li ming ;
..............page:1688-1693
Diagnosis and treatment of invasive fungal diseases in patients with severe liver diseases
ZANG Hong;,XIN Shaojie;
ZANG Hong;,XIN Shaojie;
..............page:1694-1698
Mechanism of action of direct-acting antiviral agents in treatment of chronic hepatitis C
WEN Xiaoyu;,NIU Junqi;
WEN Xiaoyu;,NIU Junqi;
..............page:1699-1705
Advances in Roussel Uclaf Causality Assessment Method for diagnosis of drug-induced liver injury and its comparison with structured expert opinion process
YU Yuecheng;,FAN Ye;
YU Yuecheng;,FAN Ye;
..............page:1706-1713
Efficacy of telbivudine combined with adefovir dipivoxil and pegylated interferon combined with entecavir as antiviral therapy for chronic hepatitis B: a comparative analysis
LI Na;,GOU Wei;,CUI Weili;
LI Na;,GOU Wei;,CUI Weili;
..............page:1714-1716
Clinical features of chronic HBV/HCV infection complicated by mild hepatic steatosis
he jia ;, li wei ;, li kuan ;, ning hui bin ;, liu jun ping ;, mao zhong shan ;, shang jia ;
he jia ;, li wei ;, li kuan ;, ning hui bin ;, liu jun ping ;, mao zhong shan ;, shang jia ;
..............page:1717-1720
Association of programmed cell death-1 gene polymorphisms with chronic hepatitis C virus infection and antiviral effect
kong ling bo ;, nan yue min ;, zhang yu guo ;, zhao su xian ;, wang rong zuo ;, fu na ;, zuo hai ling ;, su shan shan ;
kong ling bo ;, nan yue min ;, zhang yu guo ;, zhao su xian ;, wang rong zuo ;, fu na ;, zuo hai ling ;, su shan shan ;
..............page:1721-1724
Efficacy comparative of different laboratory test reagents for hepatitis C virus antibody
GUO Feibo;,WU Junzhu;
GUO Feibo;,WU Junzhu;
..............page:1725-1728
Effect of prohibitin on hepatitis C virus replication
shi juan juan ;, yang ning ;, zhang xin ;, wu feng ping ;, li mei ;, gao ning ;, jia xiao li ;, di zuo ;, dang shuang suo ;
shi juan juan ;, yang ning ;, zhang xin ;, wu feng ping ;, li mei ;, gao ning ;, jia xiao li ;, di zuo ;, dang shuang suo ;
..............page:1729-1733
Effect of entecavir combined with Fuzheng Huayu capsules on inflammatory factors and fibrosis markers in patients with compensated chronic hepatitis B-related cirrhosis
wang he ;, wang qian jun ;, sun feng bo ;, zhang xin ming ;, zuo yu qin ;
wang he ;, wang qian jun ;, sun feng bo ;, zhang xin ming ;, zuo yu qin ;
..............page:1734-1738
Value of indocyanine green test in evaluating liver reserve function in patients with hepatitis B cirrhosis
LAI Ruimin;,WANG Mingfang;,ZHU Yueyong;
LAI Ruimin;,WANG Mingfang;,ZHU Yueyong;
..............page:1739-1742
..............page:1743-1746
Elemene combined with transcatheter arterial chemoembolization in treatment of primary liver cancer: a meta-analysis
OU Zhitao;,ZHAN Yuanjing;,HUANG Chunming;
OU Zhitao;,ZHAN Yuanjing;,HUANG Chunming;
..............page:1747-1752
Value of endoscopic ultrasound and magnetic resonance cholangiopancreatography in diagnosis of obstructive jaundice
jia lei ;, guo yu ning ;, guo xiu li ;, wang tian zuo ;, lv dong ;, xu you qing ;
jia lei ;, guo yu ning ;, guo xiu li ;, wang tian zuo ;, lv dong ;, xu you qing ;
..............page:1753-1755
Clinical experience in treatment of complex intrahepatic bile duct stones by regular hepatectomy
wu xiao ;, xia zuo ;, wu jian ;, zhang ming ;
wu xiao ;, xia zuo ;, wu jian ;, zhang ming ;
..............page:1756-1759
Operation skills of endoscopic retrograde cholangiopancreatography in pancreaticobiliary patients with periampullary duodenal diverticula
ZHUANG Donghai;,ZHANG Kai;
ZHUANG Donghai;,ZHANG Kai;
..............page:1760-1762
..............page:1763-1765
Clinical features of HBV-associated acute-on-chronic liver failure induced by discontinuation of nucleoside analogues
liu xiao yan ;, chen zuo ;, xiao zuo ;, tong jing jing ;, guan chong dan ;, yan li long ;, su hai bin ;
liu xiao yan ;, chen zuo ;, xiao zuo ;, tong jing jing ;, guan chong dan ;, yan li long ;, su hai bin ;
..............page:1766-1769
Decompensated liver disease complicated by acute stroke caused by multiple factors: a clinical analysis of 15 cases
gou chun yan ;, li li ;, zhao da wei ;, li jing ying ;, luo xiao zuo ;, li xiu hui ;
gou chun yan ;, li li ;, zhao da wei ;, li jing ying ;, luo xiao zuo ;, li xiu hui ;
..............page:1770-1773
Association between serum preptin level and insulin resistance in patients with nonalcoholic fatty liver disease
wang jin jun ;, wang qin qin ;, liu xin yan ;, li ying mei ;, xiong wu jun ;
wang jin jun ;, wang qin qin ;, liu xin yan ;, li ying mei ;, xiong wu jun ;
..............page:1774-1777
Effect of blueberry and probiotics on expression of PNPLA3 and SREBP-1c in rats with nonalcoholic fatty liver disease
ZHU Juanjuan;,ZHOU Mingyu;,CHENG Mingliang;
ZHU Juanjuan;,ZHOU Mingyu;,CHENG Mingliang;
..............page:1778-1784
Drug hypersensitivity syndrome with liver failure as the main clinical manifestation: a case report
HAN Dongxia;,LI Juan;,MENG Qinghua;
HAN Dongxia;,LI Juan;,MENG Qinghua;
..............page:1785-1786
A case of acute fulminant hepatitis B with HIV infection
CHEN Shishi;,CHEN Xiaorong;,LU Yunfei;
CHEN Shishi;,CHEN Xiaorong;,LU Yunfei;
..............page:1787-1788
A case of secondary hemochromatosis
MOU Wenqian;,LI Chunyan;,CHEN Yanping;
MOU Wenqian;,LI Chunyan;,CHEN Yanping;
..............page:1789-1790
A case of primary systemic amyloidosis with hepatomegaly as the main manifestation
fan chun lei ;, wang zheng ;, li lei ;, dong pei ling ;, ding hui guo ;
fan chun lei ;, wang zheng ;, li lei ;, dong pei ling ;, ding hui guo ;
..............page:1791-1793
The role of fluoxetine in antiviral therapy for chronic hepatitis C
qin yuan ;, zhang ying ;, zhao jie ru ;, guo yong hong ;, jia zhan sheng ;
qin yuan ;, zhang ying ;, zhao jie ru ;, guo yong hong ;, jia zhan sheng ;
..............page:1794-1796
Research advances in indicators for early diagnosis of liver cirrhosis patients with renal impairment
LU Lifang;,FENG Guohe;
LU Lifang;,FENG Guohe;
..............page:1797-1800
Research advances in integrated traditional Chinese and Western medicine diagnosis and treatment of minimal hepatic encephalopathy
sun run fei ;, wu chao ;, chen zuo ;, sun ming zuo ;
sun run fei ;, wu chao ;, chen zuo ;, sun ming zuo ;
..............page:1801-1805
Current research status of mechanisms of the development and progression of liver fibrosis
XU Mingcui;,ZHANG Feng;,ZHUGE Yuzheng;
XU Mingcui;,ZHANG Feng;,ZHUGE Yuzheng;
..............page:1806-1809
The role of MAPK signaling pathway in development/progression and treatment of liver cancer
ci dan wang jiu ;, lin kun ;, lu zai ming ;, zhao xiang xuan ;, wang xiao ming ;
ci dan wang jiu ;, lin kun ;, lu zai ming ;, zhao xiang xuan ;, wang xiao ming ;
..............page:1810-1813
Role of uric acid in the development and progression of nonalcoholic fatty liver disease
li shao feng ;, liao xian hua ;, ye jun zuo ;, zhong bi hui ;
li shao feng ;, liao xian hua ;, ye jun zuo ;, zhong bi hui ;
..............page:1814-1818
Research advances in diagnosis and treatment of IgG4-associated autoimmune hepatitis
shi xiao dong ;, wei zuo ;, yu min ;, liu xing xing ;, jia zhi fang ;, wang yue zuo ;, jiang zhen yu ;
shi xiao dong ;, wei zuo ;, yu min ;, liu xing xing ;, jia zhi fang ;, wang yue zuo ;, jiang zhen yu ;
..............page:1819-1821
Research progress in biomarkers of drug-induced liver injury
guo pei ;, lu wang ;, yang wen xuan ;, hu yu lin ;
guo pei ;, lu wang ;, yang wen xuan ;, hu yu lin ;
..............page:1822-1826
Research progress in the role of autophagy in liver regeneration
HAN Weijia;,SHI Hongbo;,CHEN Yu;
HAN Weijia;,SHI Hongbo;,CHEN Yu;
..............page:1827-1831